Rothschedl, E. and Wolf, S. (2022): Tebentafusp (Kimmtrak®) as monotherapy for the treatment of human leukocyte antigen (HLA) A*02:01 positive patients with unresectable or metastatic uveal melanoma. Update May 2022. Oncology Fact Sheet Nr. 79.
Preview |
PDF
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
104kB |
Item Type: | Oncology Fact Sheet |
---|---|
Subjects: | QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology QZ Pathology > QZ 200-380 Neoplasms.Cysts WB Practice of medicine > WB 300-962 Therapeutics WW Ophthalmology > WW 101-170 Eye |
Language: | English |
Series Name: | Oncology Fact Sheet Nr. 79 |
Deposited on: | 28 Mar 2022 12:34 |
Last Modified: | 24 May 2022 10:34 |
Repository Staff Only: item control page